AIDA-1 inhibitors belong to a specialized chemical class designed to selectively target the activity of amyloid-beta A4 precursor protein-binding family A member 1 (AIDA-1). AIDA-1 is a multifaceted protein involved in diverse cellular functions, including transcriptional regulation, protein-protein interactions, and modulation of cellular signaling pathways. The inhibitors developed for AIDA-1 aim to disrupt its various functions by specifically interacting with key domains or active sites on the protein. This chemical class is characterized by a meticulously crafted molecular structure that allows for precise engagement with AIDA-1, potentially influencing its role in cellular processes.
AIDA-1 inhibitors is grounded in a detailed understanding of the molecular architecture of AIDA-1 and its interactions with other cellular components. Researchers working on this class of inhibitors seek to elucidate the specific regions on AIDA-1 that are crucial for its various functions and develop compounds that can selectively interfere with these functions. By inhibiting AIDA-1, these compounds provide valuable tools for researchers to dissect the intricate molecular pathways in which AIDA-1 is involved, shedding light on its role in cellular physiology and contributing to the broader exploration of protein regulation and cellular signaling. As scientists continue to refine the properties and optimize the efficacy of AIDA-1 inhibitors, they contribute to the ongoing efforts to unravel the complexities of cellular processes governed by this multifunctional protein.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $99.00 $335.00 $836.00 $2099.00 | 47 | |
DAPT is a gamma-secretase inhibitor. Gamma-secretase is responsible for the final cut that releases amyloid-beta from the cell membrane. By inhibiting this enzyme, the production of amyloid-beta is reduced, potentially influencing AIDA-1 function indirectly. | ||||||
Ibuprofen | 15687-27-1 | sc-200534 sc-200534A | 1 g 5 g | $52.00 $86.00 | 6 | |
Some non-steroidal anti-inflammatory drugs (NSAIDs) like Ibuprofen have been found to modulate gamma-secretase activity, shifting production from longer, aggregation-prone forms of amyloid-beta to shorter, less aggregation-prone forms. This modulation can potentially impact AIDA-1 function indirectly. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin has been shown to inhibit the aggregation of amyloid-beta peptides, potentially affecting AIDA-1 function indirectly by altering the environment in which it operates. |